MedPath

Effectiveness of Alpha and hydrocortisone %1 ointment to prevent severe skin complications among patients with breast cancer

Not Applicable
Conditions
breast cancer.
Malignant neoplasm of breast
Registration Number
IRCT2015052114333N34
Lead Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

written consent by patients; being treated by final mastectomy; at least three weeks after the last session of chemotherapy; having no burn, cut, infection and skin problems on radiation area. Exclusion criteria: having a history on collagen diseases, cases of diabetes through treatment; using systematic steroids; intolerance of radiation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching. Timepoint: Beginning of study, once a week and end of the study(6 to 7 weeks after beginning). Method of measurement: Asking the patients.;Irritation. Timepoint: Beginning of study, once a week and end of the study(6 to 7 weeks after beginning). Method of measurement: Asking the patients.;Pain levels. Timepoint: Beginning of study, once a week and end of the study(6 to 7 weeks after beginning). Method of measurement: Asking from the patients.;Severe skin complications. Timepoint: Beginning of study, once a week and end of the study(6 to 7 weeks after beginning). Method of measurement: Based on observations and physician examination, RTOG according to the criterion.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath